Pharming Group
PHAR
4 hedge funds and large institutions have $249K invested in Pharming Group in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.03% less ownership
Funds ownership: 0.03% → 0% (-0.03%)
33% less funds holding
Funds holding: 6 → 4 (-2)
89% less capital invested
Capital invested by funds: $2.17M → $249K (-$1.92M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$50.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$1.91M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12.8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $164K | +$50.5K | +4,767 | +38% |
|
|
CPA
2
Cowen Prime Advisors
New York
| $60K | – | – | – |
|
3
Morgan Stanley
New York
| $24K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$12.8K | -1,205 | -91% |
|
|
JAM
5
JW Asset Management
Miami Beach,
Florida
| – | -$1.91M | -169,225 | Closed |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$1K | -89 | Closed |
|
PHAR Hedge Fund Activity: Q3 2021 in Review
4 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q3 2021, worth a combined $249K — down 89% from $2.17M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHAR and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $50.5K. The largest seller was JW Asset Management, exiting entirely with an estimated $1.91M sold.
- 4 institutional investors held Pharming Group (PHAR) as of Q3 2021, down from 6 in Q2 2021.
- Funds reported $249K of Pharming Group stock for Q3 2021, down 89% quarter-over-quarter.
- 0 funds opened new Pharming Group positions in Q3 2021 and 2 closed out, a net change of -2 holders.
- The largest Pharming Group buyer in Q3 2021 was Jane Street, an estimated $50.5K added.
- The largest Pharming Group seller in Q3 2021 was JW Asset Management, an estimated $1.91M sold.
Based on aggregated 13F filings for Q3 2021.